The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma

Overview of attention for article published in Journal of Hematology & Oncology, February 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 14 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 10 additional patents.